While SPARC secreted from stromal fibroblasts was suggested to suppress cancer cell proliferation or migration in vitro, SPARC expression in peritumoral fibroblasts correlated with worse prognosis in pancreatic cancer [8–10]. The gene discussed is SPARC; the disease is pancreatic neoplasm.